Current Cancer Drug Targets
Volume 19, 11 Issues, 2019
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Ranking and Category
-
135th of 229 in
Oncology
Contents
Current Cancer Drug Targets, Volume 7 - Number 7
Pathobiology of Head and Neck Squamous Tumorigenesis
, 7(7): 606 - 612Adel K. El-Naggar
DOI: 10.2174/156800907782418338
Current Status and Future Perspectives of Chemoprevention in Head and Neck Cancer
, 7(7): 623 - 632Carmen M. Klass and Dong M. Shin
DOI: 10.2174/156800907782418347
Targeting Angiogenesis in Head and Neck Cancer
, 7(7): 643 - 649Nabil F. Saba, Dong M. Shin and Fadlo R. Khuri
DOI: 10.2174/156800907782418356
EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
, 7(7): 650 - 665Igor Astsaturov, Roger B. Cohen and Paul Harari
DOI: 10.2174/156800907782418365
Recent Advances in Combined Modality Therapy for Locally Advanced Head and Neck Cancer
, 7(7): 674 - 680Lori J. Wirth and Marshall R. Posner
DOI: 10.2174/156800907782418329
Recent Approaches in Chemoprevention of Prostate Cancer
, 7(7): 681 - 688Charles Y.F. Young
DOI: 10.2174/156800907782418284
Targeting MDM2 and MDMX in Retinoblastoma
, 7(7): 689 - 695Nikia A. Laurie, Chie Schin-Shih and Michael A. Dyer
DOI: 10.2174/156800907782418266
  |
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net